home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Autoantibody Production By Perturbed B Cells

  April, 5 2007 8:23
your information resource in human molecular genetics
Chronic low-level expression of a molecule called 'thymic stromal lymphopoietin' (TSLP) can greatly alter the development of antibody-producing B cells, according to a paper published online in Nature Immunology.

David Rawlings and colleagues show that low amounts of TSLP produced by epithelial tissues in skin and lung can accelerate the premature release of B cells from the bone marrow, bypassing normal mechanisms that ensure these cells do not attack 'self' tissues. Additionally, TSLP triggers an increase in a particular subset of B cells called B-1b B cells. Mice expressing an inducible form of the gene encoding TSLP had abundant autoantibodies, which were synthesized by B-1b cells and B cells from the spleen. These mice displayed early symptoms of renal disease owing to damage caused by the accumulation of these autoantibodies in kidney tissues.

TSLP expression is linked to inflammatory allergic responses. The authors' findings suggest that chronic stimulation by TSLP might contribute to the development of antibody-mediated autoimmune diseases.

Author contact:

David J. Rawlings (University of Washington School of Medicine, Seattle, WA, USA)
E-mail: drawling@u.washington.edu

Abstract available online.

(C) Nature Immunology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.